Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a publicly traded Healthcare sector company. As of November 18, 2026, TELO trades at $0.45 with a market cap of $35.44M and a P/E ratio of -1.58. TELO moved +7.07% today. Year to date, TELO is -71.28%; over the trailing twelve months it is -69.43%. Its 52-week range spans $0.42 to $4.19. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces TELO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TELO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TELO recently traded at $0.45. Market cap is $35.44M. P/E ratio is -1.58. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $0.45 |
| Market Cap | $35.44M |
| P/E Ratio |
| -1.58 |
| EPS | $-0.79 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $4.19 |
|---|
| 52-Week Low | $0.42 |
|---|
| Volume | 9.76K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $0 |
|---|
| Net Income | $-1.72M |
|---|
| Gross Margin | 0.00% |
|---|
1 analysts cover TELO: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.